Global Active Implantable Medical Devices Market 2018-2022 | Increasing Focus on R&D to Boost Demand | Technavio

According to Technavio, the global active implantable medical devices market is expected to post a CAGR of more than 6% by 2022. (Graphic: Business Wire)

LONDON--()--The global active implantable medical devices market 2018-2022 is expected to post a CAGR of more than 6% during the forecast period, according to the latest market research report by Technavio.

A key factor driving the growth of the market is the increasing prevalence of cardiac diseases, neurological disorders, and hearing loss. CVDs are estimated to cause approximately 19 million deaths globally by 2020. Every year, more than 90,000 patients are diagnosed with heart failure in the US, and three to four million patients are newly diagnosed with heart failure in Europe.

This market research report on the global active implantable medical devices market 2018-2022 also provides an analysis of the most important trends expected to impact the market outlook during the forecast period. Technavio classifies an emerging trend as a major factor that has the potential to significantly impact the market and contribute to its growth or decline.

This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing

In this report, Technavio highlights the increasing focus on R&D as one of the key emerging trends in the global active implantable medical devices market:

Global active implantable medical devices market: Increasing focus on R&D

Several vendors are increasingly focusing on the R&D of innovative AIMDs. For instance, Abbott is developing a dual chamber leadless pacemaker, the first of its kind if it succeeds. Medtronic is developing the Medtronic EV-ICD System, which is a new approach to implantable defibrillation therapy that may offer the benefits of current transvenous defibrillators.

“EBR Systems has developed an implantable pacing system called WiSE CRT, which is the world’s only wireless endocardial pacing system for CRT. It paces the heart through a tiny wireless electrode directly in the left ventricle. Thus, it eliminates the need for a pacing lead of the left ventricle in CRT and the associated complications of that lead,” says a senior analyst at Technavio.

Global active implantable medical devices market: Segmentation analysis

This market research report segments the global active implantable medical devices market by product (ICDs, Neurostimulators, Implantable pacemakers, Hearing Implants, VADs, and ILRs), by end-user (hospitals and clinics and ASCs), and geographical regions (APAC, EMEA, and the Americas).

The Americas led the market in 2017 with a market share of close to 50%, followed by APAC and EMEA respectively. The region is expected to continue to dominate the market during the forecast period.

Looking for more information on this market? Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

Market Sizing

  • Market definition
  • Market size and forecast

Five Forces Analysis

Market Segmentation

Geographical Segmentation

  • Regional comparison
  • Key leading countries

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Competitive scenario

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com

Release Summary

According to Technavio, the global active implantable medical devices market is expected to post a CAGR of more than 6% by 2022.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
www.technavio.com